Home/Filings/4/0001437749-17-012172
4//SEC Filing

NAVIDEA BIOPHARMACEUTICALS, INC. 4

Accession 0001437749-17-012172

CIK 0000810509operating

Filed

Jul 2, 8:00 PM ET

Accepted

Jul 3, 4:17 PM ET

Size

4.2 KB

Accession

0001437749-17-012172

Insider Transaction Report

Form 4
Period: 2017-06-29
Regan William J.
SVP of lobal Regulatory Strate
Transactions
  • Purchase

    Common Stock

    2017-06-29$0.53/sh+20,000$10,586172,977 total

Issuer

NAVIDEA BIOPHARMACEUTICALS, INC.

CIK 0000810509

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000810509

Filing Metadata

Form type
4
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 4:17 PM ET
Size
4.2 KB